Health News
- New Cancer Treatment For Late Stage Lung Cancer That Was Developed At Uk Is Approved For Clinical Trials
Researchers at the University of Kentucky have pioneered a new medical device for the treatment of late stage lung cancer, which has now been approved for clinical trials by the U.S. Food and Drug Administration at UK, auniversity news release says....
- U Of L Profs Get $6.3 Million To Continue Spinal Cord Research
Susan Harkema, a University of Louisville professor, talks about epidural spinal stimulation. Courier-Journal photo.Two University of Louisville professors have received a $6.3 million grant to continue their work helping paralyzed patients restore movement...
- U Of L Spinal Cord Center Brings In $13.7 Million In 2011, $64.1 Million Since 2000
The University of Louisville's spinal cord scientists attracted more than $13.7 million in outside funding in 2011 alone, and have brought in a total of $64.1 million since 2000. "This is tangible evidence of our effort to become a nationally recognized...
- New Spinal Stenosis Treatment Offers Hope
Spinal stenosis is caused by narrowing in your spine that can put pressure on the spinal cord or nerves. Symptoms include cramping, pain or numbness in your legs, back, neck, shoulders or arms, and a a loss of sensation in your extremities. It is most...
- Sinai Hospital Uses Advanced Radiosurgery To Treat Tumors And Lesions
CyberKnife® Center at Sinai Hospital Since opening the CyberKnife® Center of the Alvin & Lois Lapidus Cancer Institute in 2003, Sinai Hospital has becomerecognized as a national leader in the treatment of pancreas, lung, spine, liver, brain and...
Health News
U of L gets patents for new cancer treatments, spinal cord treatments and a new bone graft product
The University of Louisville Research Foundation has recently been awarded patents for improved cancer treatments, a new bone graft material, and therapies for spinal cord damage, and two of the inventions are already licensed and will soon be utilized by the health care system, according to a School of Medicine news release.
The patent for a new bone graft cement called Trabexus EB is one of the patent's that has been cleared by the Food and Drug Administration for use. This bone replacement cement will be used by orthopedic surgeons to repair bones damaged through injury, tumor or other defects, according to the release.
Another recently patented treatment involves a "revolutionary" new way to treat paralysis following spinal cord injury that incorporates epidural stimulation to activate the spinal cord. This treatment, along with physical training and medications, allows individuals with spinal cord injury to have voluntary control of body movements and improve heart, lung and other autonomic functions. Research participants for this treatment have been able to move and stand unassisted, with some improvements in heart, pulmonary and bladder function, according to the release.
The foundation has also received a patent for an improvement to a cancer therapy that enhances immunotherapies used for the treatment of cancer and chronic viral infections, like HIV. This new method of stimulating the immune system "has significant potential" to make immunotherapies more effective and help protect against recurrence of the disease, according to the release.
They have also received a patent for software that detects areas of depleted lung function during radiation treatment for lung cancer and other lung diseases. This new 4-D computed tomography (CT) image analysis software can be used with existing lung imaging during radiation therapy to detect early changes in lung elasticity, allowing the treatment to be adjusted to prevent permanent breathing problems, according to the release.
U of L also received a patent for a treatment that can repair the spinal cord by taking a tissue biopsy from a patient's nose, isolating the stem cells from it, and then using these stem cells to regenerate the spinal cord to repair an injury. This treatment can also be used in the treatment of Parkinson?s Disease, amyotrophic lateral sclerosis (ALS), multiple sclerosis and type 1 diabetes. This method of generating the stem cells has been licensed from UofL by RhinoCyte Inc. and is scheduled for a concept study at the University of Louisville Hospital with Phase I/II clinical trials beginning in 2016.
The patent for a new bone graft cement called Trabexus EB is one of the patent's that has been cleared by the Food and Drug Administration for use. This bone replacement cement will be used by orthopedic surgeons to repair bones damaged through injury, tumor or other defects, according to the release.
Another recently patented treatment involves a "revolutionary" new way to treat paralysis following spinal cord injury that incorporates epidural stimulation to activate the spinal cord. This treatment, along with physical training and medications, allows individuals with spinal cord injury to have voluntary control of body movements and improve heart, lung and other autonomic functions. Research participants for this treatment have been able to move and stand unassisted, with some improvements in heart, pulmonary and bladder function, according to the release.
The foundation has also received a patent for an improvement to a cancer therapy that enhances immunotherapies used for the treatment of cancer and chronic viral infections, like HIV. This new method of stimulating the immune system "has significant potential" to make immunotherapies more effective and help protect against recurrence of the disease, according to the release.
They have also received a patent for software that detects areas of depleted lung function during radiation treatment for lung cancer and other lung diseases. This new 4-D computed tomography (CT) image analysis software can be used with existing lung imaging during radiation therapy to detect early changes in lung elasticity, allowing the treatment to be adjusted to prevent permanent breathing problems, according to the release.
U of L also received a patent for a treatment that can repair the spinal cord by taking a tissue biopsy from a patient's nose, isolating the stem cells from it, and then using these stem cells to regenerate the spinal cord to repair an injury. This treatment can also be used in the treatment of Parkinson?s Disease, amyotrophic lateral sclerosis (ALS), multiple sclerosis and type 1 diabetes. This method of generating the stem cells has been licensed from UofL by RhinoCyte Inc. and is scheduled for a concept study at the University of Louisville Hospital with Phase I/II clinical trials beginning in 2016.
- New Cancer Treatment For Late Stage Lung Cancer That Was Developed At Uk Is Approved For Clinical Trials
Researchers at the University of Kentucky have pioneered a new medical device for the treatment of late stage lung cancer, which has now been approved for clinical trials by the U.S. Food and Drug Administration at UK, auniversity news release says....
- U Of L Profs Get $6.3 Million To Continue Spinal Cord Research
Susan Harkema, a University of Louisville professor, talks about epidural spinal stimulation. Courier-Journal photo.Two University of Louisville professors have received a $6.3 million grant to continue their work helping paralyzed patients restore movement...
- U Of L Spinal Cord Center Brings In $13.7 Million In 2011, $64.1 Million Since 2000
The University of Louisville's spinal cord scientists attracted more than $13.7 million in outside funding in 2011 alone, and have brought in a total of $64.1 million since 2000. "This is tangible evidence of our effort to become a nationally recognized...
- New Spinal Stenosis Treatment Offers Hope
Spinal stenosis is caused by narrowing in your spine that can put pressure on the spinal cord or nerves. Symptoms include cramping, pain or numbness in your legs, back, neck, shoulders or arms, and a a loss of sensation in your extremities. It is most...
- Sinai Hospital Uses Advanced Radiosurgery To Treat Tumors And Lesions
CyberKnife® Center at Sinai Hospital Since opening the CyberKnife® Center of the Alvin & Lois Lapidus Cancer Institute in 2003, Sinai Hospital has becomerecognized as a national leader in the treatment of pancreas, lung, spine, liver, brain and...